EKOS Receives $2.7 Million National Institutes of Health (NIH) Grant for Hemorrhagic Stroke Product Development to Address the Unmet Needs of 100,000 Americans with Intracerebral Hemorrhagic Stroke

BOTHELL, Wash.--(BUSINESS WIRE)--EKOS Corporation announced today that they received a $2.7 million grant from the National Institutes of Health (NIH) for the development of a product to provide therapy for intracerebral hemorrhagic stroke (ICH).